Table 2.
Biomarker levels.
| CD (n = 65*) | UC (n = 107*) | IBS (n = 18*) | HS (n = 20*) | p-value | |
|---|---|---|---|---|---|
| C6Ma3 (ng/mL) [range] |
2.150 [1.022–5.314] n = 59 |
2.2 [0.806–5.030] n = 100 |
2.07 [0.708–3.93] n = 18 |
3.178 [1.672–9.314] n = 16 |
CD vs. UC: > 0.9999 |
| CD vs. IBS: > 0.9999 | |||||
| CD vs. HS: 0.0122 | |||||
| UC vs. IBS: > 0.9999 | |||||
| UC vs. HS: 0.0102 | |||||
| IBS vs. HS: 0.0326 | |||||
| PRO-C6 (ng/mL) [range] |
7.012 [3.632–23-5] n = 65 |
6.811 [3.902–19.43] n = 106 |
6.59 [4.28–32.83] n = 18 |
7.00 [5.264–17.45] n = 20 |
CD vs. UC: > 0.9999 |
| CD vs. IBS: > 0.9999 | |||||
| CD vs. HS: > 0.9999 | |||||
| UC vs. IBS: > 0.9999 | |||||
| UC vs. HS: > 0.9999 | |||||
| IBS vs. HS: > 0.9999 | |||||
| CRP(mg/L) [range] |
2.35 [0.3–45] n = 64 |
2.5 [0.4–91] n = 107 |
1.55 [0.6–16] n = 18 |
1.0 [0.6–24] n = 19 |
CD vs. UC: > 0.9999 |
| CD vs. IBS: 0.3365 | |||||
| CD vs. HS: 0.1174 | |||||
| UC vs. IBS: 0.7164 | |||||
| UC vs. HS: 0.2756 | |||||
| IBS vs. HS: > 0.9999 | |||||
| FC (μg/g) [range] |
127 [5–4624] n = 58 |
141 [5–6000] n = 100 |
15 [5–69] n = 18 |
– | CD vs. UC: > 0.9999 |
| CD vs. IBS: < 0.0001 | |||||
| CD vs. HS: n.a. | |||||
| UC vs. IBS: < 0.0001 | |||||
| UC vs. HS: n.a. | |||||
| IBS vs. HS: n.a. |
Median values with ranges.
*Changes in sample size due to missing values for the specific biochemical markers. The samples size for each biomarker is stated in the table. Differences in biomarker levels were investigated with Kruskal–Wallis. p-values adjusted with Dunn’s multiple comparisons test are presented in the table. Statistical significance was defined as p < 0.05.